Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma
Open Access
- 1 June 2009
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 11 (3), 292-300
- https://doi.org/10.1215/15228517-2008-089
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione S-Transferase Genotypes in Testicular Cancer SurvivorsJournal of Clinical Oncology, 2007
- Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk MedulloblastomaJournal of Clinical Oncology, 2006
- Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based ChemotherapyClinical Cancer Research, 2006
- Neurocognitive Consequences of Risk-Adapted Therapy for Childhood MedulloblastomaJournal of Clinical Oncology, 2005
- Association of GSTP1 Polymorphism and Survival for Esophageal CancerClinical Cancer Research, 2005
- Pharmacogenetics of outcome in children with acute lymphoblastic leukemiaBlood, 2005
- Glutathione S-transferase P1 Genotype and Prognosis in Hodgkin's LymphomaClinical Cancer Research, 2005
- XRCC1 and glutathione‐S‐transferase gene polymorphisms and susceptibility to radiotherapy‐related malignancies in survivors of Hodgkin diseaseCancer, 2004
- Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapyLeukemia, 2002
- The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part ICritical Reviews in Biochemistry and Molecular Biology, 1995